SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Outlook Therapeutics, Inc. - OTLK
NEW YORK, Sept. 17, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Outlook Therapeutics, Inc. (“Outlook” or the “Company”) (NASDAQ: OTLK). Such investors are advised to contact Robert S. Willoughby at newaction@ …